Vincenzo Formica (V Formica)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 29

Top Topics

Small Cell Lung Cancer

Top Venues

Journal of clinical medicine

British journal of cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Silvia Riondino, Roberto Rosenfeld, Vincenzo Formica, Cristina Morelli, Giusy Parisi, Francesco Torino, Sabrina Mariotti, Mario Roselli
Effectiveness of Immunotherapy in Non-Small Cell Lung Cancer Patients with a Diagnosis of COPD: Is This a Hidden Prognosticator for Survival and a Risk Factor for Immune-Related Adverse Events? Cancers 16 (7) (2024)
Silvia Riondino, Roberto Rosenfeld, Vincenzo Formica, Cristina Morelli, Giusy Parisi, Francesco Torino, Sabrina Mariotti, Mario Roselli
Effectiveness of Immunotherapy in Non-Small Cell Lung Cancer Patients with a Diagnosis of COPD: Is This a Hidden Prognosticator for Survival and a Risk Factor for Immune-Related Adverse Events? Cancers 16 (7) (2024)
Silvia Riondino, Roberto Rosenfeld, Vincenzo Formica, Cristina Morelli, Giusy Parisi, Francesco Torino, Sabrina Mariotti, Mario Roselli
Effectiveness of Immunotherapy in Non-Small Cell Lung Cancer Patients with a Diagnosis of COPD: Is This a Hidden Prognosticator for Survival and a Risk Factor for Immune-Related Adverse Events? Cancers 16 (7) (2024)
Sara Mokbel, Giuilia Baciarello, Pernelle Lavaud, Aurelius Omlin, Fabio Calabrò, Richard Cathomas, Stefanie Aeppli, Pauline Parent, Patrizia Giannatempo, Kira-Lee Koster, Naara Appel, Philippe Gonnet, Gesuino Angius, Petros K Tsantoulis, Hendrick-Tobias Arkenau, Carlo Cattrini, Carlo Messina, Jean Zeghondy, Cristina Morelli, Yohann Loriot, Vincenzo Formica, Anna Patrikidou
Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint Inhibitors. Cancers 16 (8) (2024)
Sara Mokbel, Giuilia Baciarello, Pernelle Lavaud, Aurelius Omlin, Fabio Calabrò, Richard Cathomas, Stefanie Aeppli, Pauline Parent, Patrizia Giannatempo, Kira-Lee Koster, Naara Appel, Philippe Gonnet, Gesuino Angius, Petros K Tsantoulis, Hendrick-Tobias Arkenau, Carlo Cattrini, Carlo Messina, Jean Zeghondy, Cristina Morelli, Yohann Loriot, Vincenzo Formica, Anna Patrikidou
Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint Inhibitors. Cancers 16 (8) (2024)
Vincenzo Formica, Silvia Riondino, Cristina Morelli, Simona Guerriero, Federica D'Amore, Antonio Di Grazia, Giovanna Del Vecchio Blanco, Giuseppe Sica, Hendrik-Tobias Arkenau, Giovanni Monteleone, Mario Roselli
HIF2α, Hepcidin and their crosstalk as tumour-promoting signalling. British journal of cancer (2023)
Vincenzo Formica, Silvia Riondino, Cristina Morelli, Simona Guerriero, Federica D'Amore, Antonio Di Grazia, Giovanna Del Vecchio Blanco, Giuseppe Sica, Hendrik-Tobias Arkenau, Giovanni Monteleone, Mario Roselli
HIF2α, Hepcidin and their crosstalk as tumour-promoting signalling. British journal of cancer (2023)
Benedetto Neri, Roberto Mancone, Luca Savino, Sara Schiavone, Vincenzo Formica, Francesca Pizzi, Silvia Salvatori, Michelangela Mossa, Stefano Migliozzi, Mariasofia Fiorillo, Cristina Morelli, Alessandro Moscardelli, Elisabetta Lolli, Emma Calabrese, Giuseppe S Sica, Giovanni Monteleone, Livia Biancone
Mucinous and Signet-Ring Cell Colonic Adenocarcinoma in Inflammatory Bowel Disease: A Case-Control Study. Cancers 15 (15) (2023)
Brunella M Pirozzi, L Siragusa, G Baldini, M Pellicciaro, M Grande, C Efrati, R Finizio, Vincenzo Formica, Giovanna Del Vecchio Blanco, G S Sica
Influence of COVID-19 Pandemic on Colorectal Cancer Presentation, Management and Outcome during the COVID-19 Pandemic. Journal of clinical medicine 12 (4) (2023)
Vincenzo Formica, Silvia Riondino, Cristina Morelli, Simona Guerriero, Federica D'Amore, Antonio Di Grazia, Giovanna Del Vecchio Blanco, Giuseppe Sica, Hendrik-Tobias Arkenau, Giovanni Monteleone, Mario Roselli
HIF2α, Hepcidin and their crosstalk as tumour-promoting signalling. British journal of cancer (2023)
Brunella M Pirozzi, L Siragusa, G Baldini, M Pellicciaro, M Grande, C Efrati, R Finizio, Vincenzo Formica, Giovanna Del Vecchio Blanco, G S Sica
Influence of COVID-19 Pandemic on Colorectal Cancer Presentation, Management and Outcome during the COVID-19 Pandemic. Journal of clinical medicine 12 (4) (2023)
Brunella M Pirozzi, L Siragusa, G Baldini, M Pellicciaro, M Grande, C Efrati, R Finizio, Vincenzo Formica, Giovanna Del Vecchio Blanco, G S Sica
Influence of COVID-19 Pandemic on Colorectal Cancer Presentation, Management and Outcome during the COVID-19 Pandemic. Journal of clinical medicine 12 (4) (2023)
Vincenzo Formica, Silvia Riondino, Cristina Morelli, Simona Guerriero, Federica D'Amore, Antonio Di Grazia, Giovanna Del Vecchio Blanco, Giuseppe Sica, Hendrik-Tobias Arkenau, Giovanni Monteleone, Mario Roselli
HIF2α, Hepcidin and their crosstalk as tumour-promoting signalling. British journal of cancer (2023)
Cristina Morelli, Vincenzo Formica, Paolo Bossi, Michela Rofei, Simona Guerriero, Silvia Riondino, Renato Argirò, Noemi Pucci, Tonia Cenci, Luca Savino, Carla G Rinaldi, Francesco Garaci, Augusto Orlandi, Rolando M D'Angelillo, Hendrik-Tobias Arkenau, Mario Roselli
Untailored vs. Gender- and Body-Mass-Index-Tailored Skeletal Muscle Mass Index (SMI) to Assess Sarcopenia in Advanced Head and Neck Squamous Cell Carcinoma (HNSCC). Cancers 15 (19) (2023)
Brunella M Pirozzi, L Siragusa, G Baldini, M Pellicciaro, M Grande, C Efrati, R Finizio, Vincenzo Formica, Giovanna Del Vecchio Blanco, G S Sica
Influence of COVID-19 Pandemic on Colorectal Cancer Presentation, Management and Outcome during the COVID-19 Pandemic. Journal of clinical medicine 12 (4) (2023)
Sara Lonardi, Cosimo Rasola, Riccardo Lobefaro, Daniele Rossini, Vincenzo Formica, Mario Scartozzi, Giovanni Luca Frassineti, Giorgia Boscolo, Saverio Cinieri, Samantha Di Donato, Nicoletta Pella, Francesca Bergamo, Alessandra Raimondi, Ermenegildo Arnoldi, Lorenzo Antonuzzo, Cristina Granetto, Fable Zustovich, Monica Ronzoni, Silvana Leo, Federica Morano, Fotios Loupakis, Federica Buggin, Vittorina Zagonel, Angelo Paolo Dei Tos, Chiara Cremolini, Luca Boni, Filippo Pietrantonio, null null
Initial Panitumumab Plus Fluorouracil, Leucovorin, and Oxaliplatin or Plus Fluorouracil and Leucovorin in Elderly Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The PANDA Trial by GONO Foundation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Vincenzo Formica, Cristina Morelli, Veronica Conca, Maria Alessandra Calegari, Jessica Lucchetti, Emanuela Dell'Aquila, Marta Schirripa, Marco Messina, Lisa Salvatore, Federica Lo Prinzi, Giovanni Dima, Giovanni Trovato, Silvia Riondino, Mario Roselli, Ferdinandos Skoulidis, Hendrik-Tobias Arkenau, Chiara Cremolini
Irinotecan- vs. Oxaliplatin-Based Doublets in KRAS G12C -Mutated Metastatic Colorectal Cancer-A Multicentre Propensity-Score-Matched Retrospective Analysis. Cancers 15 (11) (2023)
Daniele Rossini, Carlotta Antoniotti, Sara Lonardi, Filippo Pietrantonio, Roberto Moretto, Lorenzo Antonuzzo, Alessandra Boccaccino, Federica Morano, Marco Brugia, Carmelo Pozzo, Federica Marmorino, Francesca Bergamo, Emiliano Tamburini, Alessandro Passardi, Giovanni Randon, Sabina Murgioni, Beatrice Borelli, Angela Buonadonna, Mirella Giordano, Gabriella Fontanini, Veronica Conca, Vincenzo Formica, Massimo Aglietta, Roberto Bordonaro, Giuseppe Aprile, Gianluca Masi, Luca Boni, Chiara Cremolini
Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With RAS/BRAF Wild-Type Metastatic Colorectal Cancer: The Phase III TRIPLETE Study by GONO. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (25) (2022)
Andrea Martina Guida, Bruno Sensi, Vincenzo Formica, Rolando M D'Angelillo, Mario Roselli, Giovanna Del Vecchio Blanco, Piero Rossi, Gabriella Teresa Capolupo, Marco Caricato, Giuseppe S Sica
Total neoadjuvant therapy for the treatment of locally advanced rectal cancer: a systematic minireview. Biology direct 17 (1) (2022)
Antonio Di Grazia, Davide Di Fusco, Eleonora Franzè, Marco Colella, Georgios Strimpakos, Silvia Salvatori, Vincenzo Formica, Federica Laudisi, Claudia Maresca, Alfredo Colantoni, Angela Ortenzi, Carmine Stolfi, Ivan Monteleone, Giovanni Monteleone
Hepcidin Upregulation in Colorectal Cancer Associates with Accumulation of Regulatory Macrophages and Epithelial-Mesenchymal Transition and Correlates with Progression of the Disease. Cancers 14 (21) (2022)
Edoardo Troncone, Fabio Gadaleta, Omero Alessandro Paoluzi, Cristina Maria Gesuale, Vincenzo Formica, Cristina Morelli, Mario Roselli, Luca Savino, Giampiero Palmieri, Giovanni Monteleone, Giovanna Del Vecchio Blanco
Endoscopic Ultrasound Plus Endoscopic Retrograde Cholangiopancreatography Based Tissue Sampling for Diagnosis of Proximal and Distal Biliary Stenosis Due to Cholangiocarcinoma: Results from a Retrospective Single-Center Study. Cancers 14 (7) (2022)
Cristina Morelli, Michela Rofei, Silvia Riondino, Daniela Fraboni, Francesco Torino, Augusto Orlandi, Manfredi Tesauro, Giovanna Del Vecchio Blanco, Massimo Federici, Hendrick-Tobias Arkenau, Vincenzo Formica, Mario Roselli
Immune Response in Vitamin D Deficient Metastatic Colorectal Cancer Patients: A Player That Should Be Considered for Targeted Vitamin D Supplementation. Cancers 14 (11) (2022)
Cristina Morelli, Vincenzo Formica, Elena Doldo, Silvia Riondino, Michela Rofei, Lorena Vergilii, Giampiero Palmieri, Hendrik-Tobias Arkenau, Mario Roselli, Augusto Orlandi
Concordance of Blood-Based and Normal Tissue-Based Dihydropyrimidine Dehydrogenase (DPYD) Genotyping. The oncologist 27 (5) (2022)
Mauro Bavetta, Dionisio Silvaggio, Elena Campione, Pietro Sollena, Vincenzo Formica, Deborah Coletta, Grazia Graziani, Maria Concetta Pucci Romano, Mario Roselli, Ketty Peris, Luca Bianchi
The Effects of Association of Topical Polydatin Improves the Preemptive Systemic Treatment on EGFR Inhibitors Cutaneous Adverse Reactions. Journal of clinical medicine 10 (3) (2021)
Vincenzo Formica, Cristina Morelli, Anna Patrikidou, Carmen Murias, Sabeeh Butt, Antonella Nardecchia, Jessica Lucchetti, Nicola Renzi, Kai-Keen Shiu, Mario Roselli, Hendrik-Tobias Arkenau
Gastric Inflammatory Prognostic Index (GIPI) in Patients with Metastatic Gastro-Esophageal Junction/Gastric Cancer Treated with PD-1/PD-L1 Immune Checkpoint Inhibitors. Targeted oncology 15 (3) (2021)
Vincenzo Formica, Jessica Lucchetti, Elena Doldo, Silvia Riondino, Cristina Morelli, Renato Argirò, Nicola Renzi, Daniele Nitti, Antonella Nardecchia, Emanuela Dell'Aquila, Patrizia Ferroni, Fiorella Guadagni, Giampiero Palmieri, Augusto Orlandi, Mario Roselli
Clinical Utility of Plasma KRAS, NRAS and BRAF Mutational Analysis with Real Time PCR in Metastatic Colorectal Cancer Patients-The Importance of Tissue/Plasma Discordant Cases. Journal of clinical medicine 10 (1) (2020)
Vincenzo Formica, C Morelli, A Patrikidou, K K Shiu, M Roselli, H T Arkenau
Lymph node-only metastatic gastric/gastroesophageal junction cancer and efficacy of immunotherapy. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 23 (6) (2020)
Vincenzo Formica, Michaela Benassi, Giovanna Del Vecchio Blanco, Elena Doldo, Laura Martano, Ilaria Portarena, Antonella Nardecchia, Jessica Lucchetti, Cristina Morelli, Emilia Giudice, Piero Rossi, Alessandro Anselmo, Pierpaolo Sileri, Giuseppe Sica, Augusto Orlandi, Riccardo Santoni, Mario Roselli
Hemoglobin level and XRCC1 polymorphisms to select patients with locally advanced rectal cancer candidate for neoadjuvant chemoradiotherapy with concurrent capecitabine and a platinum salt. Medical oncology (Northwood, London, England) 35 (6) (2018)
Vincenzo Formica, Alberto Zaniboni, Fotios Loupakis, Mario Roselli
Noninferiority of three months versus six months of oxaliplatin-based adjuvant chemotherapy for resected colon cancer. How should IDEA findings affect clinical practice? International journal of cancer 143 (10) (2018)